Elanco Animal Health Inc ELAN reported a Q3 FY23 revenue of $1.068 billion, up 4% reported growth or 5% excluding the impact of foreign exchange rates, above…
Elanco Animal Health Inc (NYSE: ELAN) reported a Q3 FY23 revenue of $1.068 billion, up 4% reported growth or 5% excluding the impact of foreign exchange rates, above the
Elanco Animal Health Inc. (ELAN) reported Tuesday a net loss for the third quarter of $1.10 billion or $2.22 per share, sharply wider than $65.0 million or $0.13 per share in the prior-year quarter.
The trip, set for Nov. 14-17, will primarily focus on the $1 billion Gardens by the Bay nature park development, which encompasses 250 acres near the Singapore’s southern coast.